BioVaxys Technology's total assets for Q2 2025 were C$1.10M, a decrease of -14.13% from the previous quarter. BVAXF total liabilities were C$3.83M for the fiscal quarter, a 26.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.